Tenaya Therapeutics, Inc. Common Stock (TNYA) News

Latest headlines that mention TNYA, newest first · each headline opens the original publisher

TNYA quote

Last price: $0.41
Day change: +5.04%
Next earnings: 2026-11-09

Quote & chart Expected move Insider trading IV rank history

TNYA headlines

latest coverage

Seeking Alpha News 1mo ago

Tenaya Therapeutics, Inc. (TNYA) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript

General T2TNYA

Investing.com 1mo ago

FDA grants RMAT designation to Tenaya’s TN-401 gene therapy

General T3TNYA

Investing.com 2mo ago

Tenaya therapeutics CMO Tingley Whittemore sells $5,267 in stock

General T3TNYA

Investing.com 2mo ago

Tenaya therapeutics CEO Ali Faraz sells $15.8k in company shares

General T3TNYA

Seeking Alpha News 2mo ago

Tenaya Therapeutics, Inc. (TNYA) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript

General T2TNYA

Seeking Alpha 2mo ago

Tenaya Therapeutics GAAP EPS of -$0.20 misses by $0.13, revenue of $1.11M misses by $8.89M

Earnings T2TNYA

Seeking Alpha News 4mo ago

Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

General T2TNYA

Seeking Alpha News 4mo ago

Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow

General T2TNYA

Seeking Alpha News 4mo ago

Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM Transcript

General T2TNYA

Seeking Alpha News 4mo ago

Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM - Slideshow

General T2TNYA

Investing.com 4mo ago

Tenaya reports interim data from gene therapy trial for rare heart condition

General T3TNYA

Investing.com 5mo ago

Tenaya Therapeutics CEO Ali Faraz sells $2,689 in shares

General T3TNYA

Seeking Alpha News 5mo ago

Tenaya Therapeutics, Inc. (TNYA) Discusses RIDGE-1 Phase Ib/II Data on TN-401 Gene Therapy for PKP2-Associated ARVC - Slideshow

General T2TNYA

Seeking Alpha News 5mo ago

Tenaya Therapeutics, Inc. (TNYA) Discusses RIDGE-1 Phase Ib/II Data on TN-401 Gene Therapy for PKP2-Associated ARVC Transcript

General T2TNYA

Seeking Alpha News 5mo ago

Tenaya Therapeutics, Inc. (TNYA) Presents at Heart Failure 2026 - Slideshow

General T2TNYA

Investing.com 5mo ago

Tenaya reports interim gene therapy trial results for heart condition

General T3TNYA

Seeking Alpha 5mo ago

Tenaya Therapeutics GAAP EPS of -$0.09, revenue of $0.2M

Earnings T2TNYA

TNYA news alerts

Get an alert by email or push when a new headline mentions TNYA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.